Pre-market hot trades in US stocks: Semtech pre-market down 3.61%; Lumentum pre-market down 3.18%
I'm LongbridgeAI, I can summarize articles.Semtech pre-market down 3.61%; Lumentum pre-market down 3.18%; The Growhub pre-market up 61.08%; Liminatus Pharma pre-market up 41.75%; AtaiBeckley pre-market up 34.33%
Pre-market Hot Trades in US Stocks
Semtech pre-market down 3.61%. Based on recent key news:
-
On July 14, Semtech President and CEO HOU Qingqiang sold 2,000 shares of common stock at a price of $133 per share. This move may raise market concerns about insider confidence in the company, leading to stock price fluctuations.
-
On July 13, analysts pointed out that Semtech is collaborating with multiple clients to develop multi-wavelength DWDM lasers and TIA and driver array solutions for NPO applications. Despite orders and backlogs reaching new highs, the stock price still fell by about 1%.
-
On July 13, GF Securities projected that Semtech's revenue will reach $466 million in fiscal year 2027 and $1.22 billion in fiscal year 2028. Analysts believe that the adoption of NPO will become the next growth driver for the company. The transformation of optical architecture is driving industry development.
Lumentum pre-market down 3.18%. Based on recent news,
-
On July 15, Lumentum reported that supply constraints led to shipments falling short of demand, but operational leverage should drive diluted earnings per share above expectations by 3%-4%. Analysts expect the company to guide revenue between $1.15 billion and $1.2 billion on September 26, representing approximately 120% year-over-year growth. However, slightly higher investor expectations led to a decline in stock price.
-
On July 14, Israeli chip manufacturer Tower Semiconductor announced a $3 billion investment to strengthen chip manufacturing in Japan, which boosted optical communication stocks collectively, but Lumentum failed to sustain gains and instead fell pre-market.
-
On July 13, Lumentum plans to announce its fourth quarter and full-year financial report for fiscal year 2026 on August 11. The market has high expectations for the financial report, but supply chain issues may impact performance, leading to stock price fluctuations. The optical communication industry is viewed positively in the long term, but supply chain issues remain.
Top Gainers in Pre-market US Stocks
The Growhub pre-market up 61.08%. Based on recent news,
-
On July 15, The Growhub Ltd. released its latest announcement through the EDGAR system of the U.S. Securities and Exchange Commission. The announcement indicated significant progress in the company's future business development, boosting market confidence and leading to a substantial rise in stock price.
-
On July 15, The Growhub Ltd.'s announcement mentioned that the company plans to undertake a series of strategic investments and expansions in the future, further enhancing investor confidence and driving up the stock price.
-
On July 15, The Growhub Ltd.'s announcement also noted that the company has made significant breakthroughs in technology research and development, which the market interpreted as a sign that the company's future profitability will significantly improve, further driving up the stock price. Market interest in tech stocks has increased, with noticeable capital inflows Liminatus Pharma pre-market rose 41.75%, with no significant news recently. The trading is active, and the capital flow is evident. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation.
AtaiBeckley pre-market rose 34.33%. Based on recent key news:
-
On July 16, Eli Lilly announced it would acquire AtaiBeckley for $6.75 per share in cash, with a total transaction value of approximately $2.8 billion. This news significantly boosted AtaiBeckley's stock price.
-
On July 15, Bloomberg reported that Eli Lilly was in acquisition talks with AtaiBeckley, expecting to reach an agreement at a premium. This news sparked strong market interest in AtaiBeckley, with the stock price soaring 66% in after-hours trading.
-
On July 16, analysts pointed out that the Trump administration's policy support accelerated the approval process for psychedelic drugs, attracting more capital into the industry, further driving up AtaiBeckley's stock price. The psychedelic drug industry is supported by policy, with evident capital inflow
